FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783227487> ?p ?o ?g. }

• W2783227487 endingPage "1705737" @default.
• W2783227487 startingPage "1705737" @default.
• W2783227487 abstract "Nanomedicine has shown unprecedented potential for cancer theranostics. Nucleic acid (e.g., DNA and RNA) nanomedicines are of particular interest for combination therapy with chemotherapeutics. However, current nanotechnologies to construct such nucleic acid nanomedicines, which rely on chemical conjugation or physical complexation of nucleic acids with chemotherapeutics, have restrained their clinical translation due to limitations such as low drug loading efficiency and poor biostability. Herein, in situ rolling circle transcription (RCT) is applied to synthesize short hairpin RNA (shRNA) on amphiphilic DNA-polylactide (PLA) micelles. Core-shell PLA@poly-shRNA structures that codeliver a high payload of doxorubicin (Dox) and multidrug resistance protein 1 (MDR1) targeted shRNA for MDR breast cancer (BC) therapy are developed. DNA-PLA conjugates are first synthesized, which then self-assemble into amphiphilic DNA-PLA micelles; next, using the conjugated DNA as a promoter, poly-shRNA is synthesized on DNA-PLA micelles via RCT, generating PLA@poly-shRNA microflowers; and finally, microflowers are electrostatically condensed into nanoparticles using biocompatible and multifunctional poly(ethylene glycol)-grafted polypeptides (PPT-g-PEG). These PLA@poly-shRNA@PPT-g-PEG nanoparticles are efficiently delivered into MDR breast cancer cells and accumulated in xenograft tumors, leading to MDR1 silencing, intracellular Dox accumulation, potentiated apoptosis, and enhanced tumor therapeutic efficacy. Overall, this nanomedicine platform is promising to codeliver anticancer nucleic acid therapeutics and chemotherapeutics." @default.
• W2783227487 created "2018-01-26" @default.
• W2783227487 creator A5012099287 @default.
• W2783227487 creator A5018249388 @default.
• W2783227487 creator A5031311056 @default.
• W2783227487 creator A5031447537 @default.
• W2783227487 creator A5056053058 @default.
• W2783227487 creator A5057059532 @default.
• W2783227487 creator A5072004686 @default.
• W2783227487 creator A5076944720 @default.
• W2783227487 creator A5083507260 @default.
• W2783227487 creator A5085590034 @default.
• W2783227487 creator A5088055918 @default.
• W2783227487 creator A5091335380 @default.
• W2783227487 date "2018-01-15" @default.
• W2783227487 modified "2023-09-30" @default.
• W2783227487 title "In Situ shRNA Synthesis on DNA-Polylactide Nanoparticles to Treat Multidrug Resistant Breast Cancer" @default.
• W2783227487 cites W1830454849 @default.
• W2783227487 cites W1843302206 @default.
• W2783227487 cites W1974242784 @default.
• W2783227487 cites W1982902233 @default.
• W2783227487 cites W1983718760 @default.
• W2783227487 cites W1985498995 @default.
• W2783227487 cites W1999430578 @default.
• W2783227487 cites W2000071382 @default.
• W2783227487 cites W2009993736 @default.
• W2783227487 cites W2011569859 @default.
• W2783227487 cites W2021385919 @default.
• W2783227487 cites W2042619042 @default.
• W2783227487 cites W2043580019 @default.
• W2783227487 cites W2046542140 @default.
• W2783227487 cites W2048735112 @default.
• W2783227487 cites W2048743137 @default.
• W2783227487 cites W2059978839 @default.
• W2783227487 cites W2066608200 @default.
• W2783227487 cites W2084277192 @default.
• W2783227487 cites W2098547460 @default.
• W2783227487 cites W2109997465 @default.
• W2783227487 cites W2117786997 @default.
• W2783227487 cites W2117817585 @default.
• W2783227487 cites W2119505328 @default.
• W2783227487 cites W2122326980 @default.
• W2783227487 cites W2126163864 @default.
• W2783227487 cites W2131487381 @default.
• W2783227487 cites W2149896139 @default.
• W2783227487 cites W2157337481 @default.
• W2783227487 cites W2163678477 @default.
• W2783227487 cites W2165836181 @default.
• W2783227487 cites W2190858682 @default.
• W2783227487 cites W2280520067 @default.
• W2783227487 cites W2315302880 @default.
• W2783227487 cites W2320312730 @default.
• W2783227487 cites W2512016627 @default.
• W2783227487 cites W2555945825 @default.
• W2783227487 cites W2559177805 @default.
• W2783227487 cites W2586524855 @default.
• W2783227487 cites W2917837889 @default.
• W2783227487 cites W4237229340 @default.
• W2783227487 cites W4362217323 @default.
• W2783227487 doi "https://doi.org/10.1002/adma.201705737" @default.
• W2783227487 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29333658" @default.
• W2783227487 hasPublicationYear "2018" @default.
• W2783227487 type Work @default.
• W2783227487 sameAs 2783227487 @default.
• W2783227487 citedByCount "60" @default.
• W2783227487 countsByYear W27832274872018 @default.
• W2783227487 countsByYear W27832274872019 @default.
• W2783227487 countsByYear W27832274872020 @default.
• W2783227487 countsByYear W27832274872021 @default.
• W2783227487 countsByYear W27832274872022 @default.
• W2783227487 countsByYear W27832274872023 @default.
• W2783227487 crossrefType "journal-article" @default.
• W2783227487 hasAuthorship W2783227487A5012099287 @default.
• W2783227487 hasAuthorship W2783227487A5018249388 @default.
• W2783227487 hasAuthorship W2783227487A5031311056 @default.
• W2783227487 hasAuthorship W2783227487A5031447537 @default.
• W2783227487 hasAuthorship W2783227487A5056053058 @default.
• W2783227487 hasAuthorship W2783227487A5057059532 @default.
• W2783227487 hasAuthorship W2783227487A5072004686 @default.
• W2783227487 hasAuthorship W2783227487A5076944720 @default.
• W2783227487 hasAuthorship W2783227487A5083507260 @default.
• W2783227487 hasAuthorship W2783227487A5085590034 @default.
• W2783227487 hasAuthorship W2783227487A5088055918 @default.
• W2783227487 hasAuthorship W2783227487A5091335380 @default.
• W2783227487 hasConcept C104317684 @default.
• W2783227487 hasConcept C11268172 @default.
• W2783227487 hasConcept C15083742 @default.
• W2783227487 hasConcept C155672457 @default.
• W2783227487 hasConcept C15920480 @default.
• W2783227487 hasConcept C159985019 @default.
• W2783227487 hasConcept C171250308 @default.
• W2783227487 hasConcept C178790620 @default.
• W2783227487 hasConcept C184651966 @default.
• W2783227487 hasConcept C185592680 @default.
• W2783227487 hasConcept C190232843 @default.
• W2783227487 hasConcept C192562407 @default.
• W2783227487 hasConcept C24107716 @default.
• W2783227487 hasConcept C2776694085 @default.

• next